Investigating the genetic landscape of cancer in Jordan: a step toward personalized care

Abstract Cancer is a leading cause of mortality worldwide, with genetic predispositions playing a key role in disease onset. This review assessed over 80 published genetic studies involving more than 3000 Jordanian cancer patients to explore the hereditary landscape of cancer in Jordan. Breast, colo...

Full description

Saved in:
Bibliographic Details
Main Authors: Laith N. AL-Eitan, Amneh H. Tarkhan, Haneen O. Ali, Maryam K. Alasmar, Mansour A. Alghamdi
Format: Article
Language:English
Published: BMC 2025-07-01
Series:European Journal of Medical Research
Subjects:
Online Access:https://doi.org/10.1186/s40001-025-02799-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849335045819465728
author Laith N. AL-Eitan
Amneh H. Tarkhan
Haneen O. Ali
Maryam K. Alasmar
Mansour A. Alghamdi
author_facet Laith N. AL-Eitan
Amneh H. Tarkhan
Haneen O. Ali
Maryam K. Alasmar
Mansour A. Alghamdi
author_sort Laith N. AL-Eitan
collection DOAJ
description Abstract Cancer is a leading cause of mortality worldwide, with genetic predispositions playing a key role in disease onset. This review assessed over 80 published genetic studies involving more than 3000 Jordanian cancer patients to explore the hereditary landscape of cancer in Jordan. Breast, colorectal, and lung cancers were the most studied, with BRCA1/2 and TP53 among the most frequently mutated genes. While somatic mutations such as KRAS and EGFR were commonly reported in tumor studies, our primary focus is on germline PSVs that may indicate population-specific genetic risks, including BRCA1 exon 11 mutations in breast cancer and p.Gly12Asp in KRAS for colorectal cancer. Unique or novel PSVs, particularly in BRCA2 and AKT1, were also reported, suggesting potential founder effects or region-specific genetic risks. These findings support integrating multigene panel testing and genetic counseling into national cancer prevention strategies to improve early detection and personalized care in Jordan.
format Article
id doaj-art-eea93f1e6f1d4842a41318b4f779b15d
institution Kabale University
issn 2047-783X
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series European Journal of Medical Research
spelling doaj-art-eea93f1e6f1d4842a41318b4f779b15d2025-08-20T03:45:24ZengBMCEuropean Journal of Medical Research2047-783X2025-07-013011910.1186/s40001-025-02799-7Investigating the genetic landscape of cancer in Jordan: a step toward personalized careLaith N. AL-Eitan0Amneh H. Tarkhan1Haneen O. Ali2Maryam K. Alasmar3Mansour A. Alghamdi4Department of Biotechnology and Genetic Engineering, Jordan University of Science and TechnologyDepartment of Biotechnology and Genetic Engineering, Jordan University of Science and TechnologyDepartment of Biotechnology and Genetic Engineering, Jordan University of Science and TechnologyDepartment of Biotechnology and Genetic Engineering, Jordan University of Science and TechnologyDepartment of Anatomy, College of Medicine, King Khalid UniversityAbstract Cancer is a leading cause of mortality worldwide, with genetic predispositions playing a key role in disease onset. This review assessed over 80 published genetic studies involving more than 3000 Jordanian cancer patients to explore the hereditary landscape of cancer in Jordan. Breast, colorectal, and lung cancers were the most studied, with BRCA1/2 and TP53 among the most frequently mutated genes. While somatic mutations such as KRAS and EGFR were commonly reported in tumor studies, our primary focus is on germline PSVs that may indicate population-specific genetic risks, including BRCA1 exon 11 mutations in breast cancer and p.Gly12Asp in KRAS for colorectal cancer. Unique or novel PSVs, particularly in BRCA2 and AKT1, were also reported, suggesting potential founder effects or region-specific genetic risks. These findings support integrating multigene panel testing and genetic counseling into national cancer prevention strategies to improve early detection and personalized care in Jordan.https://doi.org/10.1186/s40001-025-02799-7JordanCancerGeneticsEarly screeningGenetic testing
spellingShingle Laith N. AL-Eitan
Amneh H. Tarkhan
Haneen O. Ali
Maryam K. Alasmar
Mansour A. Alghamdi
Investigating the genetic landscape of cancer in Jordan: a step toward personalized care
European Journal of Medical Research
Jordan
Cancer
Genetics
Early screening
Genetic testing
title Investigating the genetic landscape of cancer in Jordan: a step toward personalized care
title_full Investigating the genetic landscape of cancer in Jordan: a step toward personalized care
title_fullStr Investigating the genetic landscape of cancer in Jordan: a step toward personalized care
title_full_unstemmed Investigating the genetic landscape of cancer in Jordan: a step toward personalized care
title_short Investigating the genetic landscape of cancer in Jordan: a step toward personalized care
title_sort investigating the genetic landscape of cancer in jordan a step toward personalized care
topic Jordan
Cancer
Genetics
Early screening
Genetic testing
url https://doi.org/10.1186/s40001-025-02799-7
work_keys_str_mv AT laithnaleitan investigatingthegeneticlandscapeofcancerinjordanasteptowardpersonalizedcare
AT amnehhtarkhan investigatingthegeneticlandscapeofcancerinjordanasteptowardpersonalizedcare
AT haneenoali investigatingthegeneticlandscapeofcancerinjordanasteptowardpersonalizedcare
AT maryamkalasmar investigatingthegeneticlandscapeofcancerinjordanasteptowardpersonalizedcare
AT mansouraalghamdi investigatingthegeneticlandscapeofcancerinjordanasteptowardpersonalizedcare